Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12494
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDo, Hongdoen
dc.contributor.authorDobrovic, Alexanderen
dc.date.accessioned2015-05-16T02:11:58Z-
dc.date.available2015-05-16T02:11:58Z-
dc.date.issued2014-11-24en
dc.identifier.citationClinical Chemistry 2014; 61(1): 64-71en
dc.identifier.govdoc25421801en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/12494en
dc.description.abstractPrecision medicine is dependent on identifying actionable mutations in tumors. Accurate detection of mutations is often problematic in formalin-fixed paraffin-embedded (FFPE) tissues. DNA extracted from formalin-fixed tissues is fragmented and also contains DNA lesions that are the sources of sequence artifacts. Sequence artifacts can be difficult to distinguish from true mutations, especially in the context of tumor heterogeneity, and are an increasing interpretive problem in this era of massively parallel sequencing. Understanding of the sources of sequence artifacts in FFPE tissues and implementation of preventative strategies are critical to improve the accurate detection of actionable mutations.This mini-review focuses on DNA template lesions in FFPE tissues as the source of sequence artifacts in molecular analysis. In particular, fragmentation, base modification (including uracil and thymine deriving from cytosine deamination), and abasic sites are discussed as indirect or direct sources of sequence artifacts. We discuss strategies that can be implemented to minimize sequence artifacts and to distinguish true mutations from sequence artifacts. These strategies are applicable for the detection of actionable mutations in both single amplicon and massively parallel amplicon sequencing approaches.Because FFPE tissues are usually the only available material for DNA analysis, it is important to maximize the accurate informational content from FFPE DNA. Careful consideration of each step in the work flow is needed to minimize sequence artifacts. In addition, validation of actionable mutations either by appropriate experimental design or by orthogonal methods should be considered.en
dc.language.isoenen
dc.subject.otherArtifactsen
dc.subject.otherDNA.geneticsen
dc.subject.otherDNA Damageen
dc.subject.otherFalse Negative Reactionsen
dc.subject.otherFalse Positive Reactionsen
dc.subject.otherFormaldehydeen
dc.subject.otherHumansen
dc.subject.otherNeoplasms.geneticsen
dc.subject.otherParaffin Embeddingen
dc.subject.otherReproducibility of Resultsen
dc.subject.otherSequence Analysis, DNAen
dc.subject.otherTemplates, Geneticen
dc.subject.otherTissue Fixationen
dc.titleSequence artifacts in DNA from formalin-fixed tissues: causes and strategies for minimization.en
dc.typeJournal Articleen
dc.identifier.journaltitleClinical chemistryen
dc.identifier.affiliationTranslational Genomics and Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Pathology, University of Melbourne, Parkville, Victoria, Australiaen
dc.identifier.affiliationSchool of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australiaen
dc.identifier.doi10.1373/clinchem.2014.223040en
dc.description.pages64-71en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/25421801en
dc.type.austinJournal Articleen
local.name.researcherDobrovic, Alexander
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.languageiso639-1en-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptSurgery (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

148
checked on Jan 9, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.